Filtros de búsqueda

Lista de obras de Huub van Vliet

Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.

artículo científico publicado en 2006

Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences

artículo científico publicado en 2005

Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease

artículo científico publicado en 2006

Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management

artículo científico publicado en 2009

Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications

artículo científico publicado en 2006

Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.

artículo científico publicado en 2007

Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.

scientific article published on 08 June 2009

Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings

artículo científico publicado en 2009

New TPO treatment schedules of increased safety and efficacy: pre‐clinical validation of a thrombopoiesis simulation model ⬇️

artículo científico publicado el 1 de noviembre de 2003

Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin

artículo científico publicado en 2006

The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera

artículo científico publicado en 2006

The value of alloantibody detection in predicting response to HLA-matched platelet transfusions

artículo científico publicado en 2004

What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?

artículo científico publicado en 2004

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda